TY  - JOUR 
AU  - Ruiz, S.
AU  - Gil, J.
AU  - Biagetti, B.
AU  - Venegas, E.
AU  - Cámara, R.
AU  - Garcia-Centeno, R.
AU  - Gálvez, M.-Á.
AU  - Picó, A.
AU  - Maraver, S.
AU  - González, I.
AU  - Abellán, P.
AU  - Trincado, P.
AU  - Herrera, M.
AU  - Olvera, P.
AU  - Xifra, G.
AU  - Bernabeu Morón, Ignacio
AU  - Serra-Soler, G.
AU  - Azriel, S.
AU  - García, L.
AU  - Carvalho, D.
AU  - Jordà, M.
AU  - Valassi, E.
AU  - Puig, J.
AU  - Puig-Domingo, M.
PY  - 2023
SN  - 1365-2265
UR  - http://hdl.handle.net/20.500.11940/21705
AB  - Objective: Hyperintensity signal in T2-weighted magnetic resonance imaging (MRI) has been related to better therapeutic response during pasireotide treatment in acromegaly. The aim of the study was to evaluate T2 MRI signal intensity and its relation...
LA  - eng
KW  - Humans
KW  - Female
KW  - Male
KW  - Acromegaly
KW  - Insulin-Like Growth Factor I
KW  - Adenoma
KW  - Human Growth Hormone
KW  - Magnetic Resonance Imaging
KW  - Treatment Outcome
KW  - Octreotide
TI  - Magnetic resonance imaging as a predictor of therapeutic response to pasireotide in acromegaly
DO  - 10.1111/cen.14946
T2  - Clinical Endocrinology
M2  - 378
KW  - AS Santiago
KW  - CHUS
VL  - 99
ER  -